You will join Hagedorn Research Institute in Gentofte, Denmark - a fully integrated part of Novo Nordisk A/S. We are expanding our scope with early applied research. Our objective is to feed Novo Nordisk's diabetes pipeline with new protein drugs, and ultimately to find a cure for diabetes and its complications. To help us reach our goal, we are re...
View the full article